Andrew H. Lane, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 146,848 shares at $81.42 ($12.0M) on 2019-06-12, disclosed to the SEC on 2019-06-14.
Seasonal sale ($12.0M) by Executive Vice President — this insider has traded ABT in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.42 | 73,424 | $6.0M | 50.0% |
| 2 | $81.42 | 73,424 | $6.0M | 50.0% |
| Total | $81.42 avg | 146,848 | $12.0M | 100% |
| Filing → |
| ABT | SELL | 2020-05-07 | $7.4M | — | Filing → |
| ABT | SELL | 2018-08-31 | $1.2M | — | Filing → |